Business Context and Reporting Period
This Form 8-K is a Current Report filed by Connexa Sports Technologies Inc. (trading symbol: YYAI) on July 9, 2025. The filing addresses a corporate governance issue regarding compliance with Nasdaq listing standards following the resignation of a board member.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance and does not contain financial performance data.
Material Changes
On June 12, 2025, Warren Andrew Thomson resigned from the Board of Directors and the Audit Committee. Consequently, on July 9, 2025, the Company received a Notice from Nasdaq indicating non-compliance with Listing Rule 5605. The Company currently has four directors, only two of whom are independent, and the Audit Committee consists of only two independent directors, failing the requirement for a majority of independent directors and a minimum of three independent directors on the Audit Committee.
Guidance, Outlook, and Risks
- Compliance Plan: The Company intends to appoint an additional independent director to the Board and Audit Committee to regain compliance.
- Cure Period: Nasdaq has granted a cure period until the earlier of the Company's next annual stockholders' meeting or June 12, 2026. If the next annual meeting occurs before December 9, 2025, compliance must be evidenced by December 9, 2025.
- Trading Status: The Notice has no immediate effect on the listing or trading of the Company's common stock.
- Risks: The filing includes standard forward-looking statement disclaimers regarding the ability to regain compliance, noting that actual results may differ due to risks and uncertainties.
Investor Verification Checklist
- Verify the timeline for the appointment of a new independent director to ensure compliance before the December 9, 2025, or June 12, 2026, deadline.
- Confirm the date of the next annual stockholders' meeting to determine the exact compliance deadline.
- Monitor future filings for updates on the Board composition and any further correspondence from Nasdaq.
- Review the Company's most recent 10-K or 10-Q for financial data, as this 8-K contains no financial metrics.